Quantum Dots and their Potential Role in Cancer Theranostics

• Published in: Critical reviews in therapeutic drug carrier systems Vol. 32; no. 6; p. 461
• Main Authors: Tripathi, S K, Kaur, Gurvir, Khurana, Rajneet Kaur, Kapoor, Sonia, Singh, Bhupinder
• Format: Journal Article
• Language: English
• Published: United States 2015
• Subjects: Animals; Diagnostic Imaging - methods; Drug Delivery Systems - methods; Fluorescent Dyes - administration & dosage; Fluorescent Dyes - analysis; Humans; Models, Chemical; Neoplasms - diagnosis; Neoplasms - therapy; Photochemotherapy - methods; Quantum Dots - administration & dosage; Quantum Dots - adverse effects
• ISSN: 2162-660X
• DOI: 10.1615/CritRevTherDrugCarrierSyst.2015012360

The emergence of cancer nanomedicine is the result of fruitful advances in the fields of nanotechnology, bioimaging, formulation development, and molecular biology. Quantum dots (QDs) are the luminescent nanocrystals (NCs) that provide a multifunctional platform for imaging the biosystems following controlled delivery of therapeutic drugs, proteins, peptides, oligonucleotides, and genes. These engineered fluorescent probes with integrated imaging and carrier functionalities have become excellent tools for molecular diagnostics and delivery of therapeutics molecules. Flexible surface chemistry, unique optical properties, high sensitivity, and multiplexing capabilities of QDs certainly make them a most promising tool for personalized medicine. This review focuses on state-of-art advances in synthesizing QDs and highlights the approaches used for functionalization of QDs with desired ligands for targeted carriage to specific sites. Discussed is the role of QDs in antitumor therapy through drug delivery and gene delivery and the recently emerged photodynamic therapy (PDT). We also endeavor to critically address the major impediments in the clinical development of these multifunctional nanoplatforms, with a special focus on plausible advancements for the near future.